Investor Relations

Madeira Therapeutics is based in Kansas and therefore leverages the opportunities and advantages of the state's angel tax credits.  Additionally, the company plans to apply for additional funding through the Kansas Technology Enterprise Corporation (KTEC) and Kansas Bioscience Authority.

For a complete corporate profile, financial summary and details on investment opportunities, please contact Peter Joiner at (913) 661-1962 or fill out the Request Information form.

Click here to download a Madeira Therapeutics investor press kit, with helpful Q&A for interested investors.